Journal
ORGANIC LETTERS
Volume 24, Issue 8, Pages 1711-1715Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.2c00347
Keywords
-
Categories
Funding
- EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/L015838/1]
- GlaxoSmithKline
- Vertex
- AstraZeneca
- Diamond Light Source
- Defense Science and Technology Laboratory
- Evotec
- Janssen
- Novartis
- Pfizer
- Syngenta
- Takeda
- UCB
- China Scholarship Council
Ask authors/readers for more resources
A new N-silyl sulfinylamine reagent has been developed for the rapid synthesis of a wide range of (hetero)aryl, alkenyl, and alkyl primary sulfinamides, which can be further converted to NH-sulfonimidamides. This two-step sequence is straightforward and provides a modular approach for the synthesis of NH-sulfonimidamides with flexibility in reaction components.
A new N-silyl sulfinylamine reagent allows the rapid preparation of a broad range of (hetero)aryl, alkenyl, and alkyl primary sulfinamides, using Grignard, organolithium, or organozinc reagents to introduce the carbon fragment. Treatment of these primary sulfinamides with an amine in the presence of a hypervalent iodine reagent leads directly to NH-sulfonimidamides. This two-step sequence is straightforward to perform and provides a modular approach to sulfonimidamides, allowing ready variation of both reaction components, including primary and secondary amines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available